Quantum Biopharma (QNTM) Change in Cash (2019 - 2026)
Quantum Biopharma recorded quarterly Change in Cash of $2.4 million in Q1 2026, up 66.95% quarter-over-quarter from $1.5 million in Q4 2025, and up 198.34% year-over-year from $816689.6 in Q1 2025.
Quantum Biopharma's Change in Cash history runs 6 years deep, the most recent figure standing at $2.4 million for Q1 2026.
- In Q1 2026, Change in Cash rose 198.34% year-over-year to $2.4 million; the TTM figure through Mar 2026 stood at $823595.0 (up 112.72% YoY), while the FY2025 annual figure was -$4.1 million, down 226.3% from the prior year.
- Change in Cash came in at $2.4 million for Q1 2026 at Quantum Biopharma, up from $1.5 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $2.9 million in Q4 2024 to a low of -$6.7 million in Q1 2022.
- A 4-year average of -$706436.8 and a median of -$619023.5 in 2024 frame the typical range for Change in Cash.
- Across the five-year window, Change in Cash sank 464.13% in 2025 and jumped 198.34% in 2026, its largest moves.
- Quantum Biopharma's Change in Cash stood at -$6.7 million in 2022, then jumped by 143.01% to $2.9 million in 2024, then plunged by 49.25% to $1.5 million in 2025, then surged by 66.95% to $2.4 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered $2.4 million, $1.5 million, and -$1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -153.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.61 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 57.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.44 Mn |
| Dec 31, 2025 | 1.46 Mn |
| Sep 30, 2025 | -1.05 Mn |
| Jun 30, 2025 | -2.02 Mn |
| Mar 31, 2025 | -2.48 Mn |
| Dec 31, 2024 | 2.88 Mn |
| Sep 30, 2024 | -186,415.00 |
| Mar 31, 2022 | -6.69 Mn |
| Sep 30, 2020 | 4.97 Mn |
| Jun 30, 2020 | 2.73 Mn |
| Mar 31, 2020 | 239,135.30 |
| Mar 31, 2019 | -3.03 Mn |